Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Another study assessing the addition of GLP-1 analogues (liraglutide or exenatide) to existing insulin therapy in type 2 diabetes patients showed reductions in HbA1c, body weight and insulin dosage
The cardiovascular outcomes trial reports late 2027 or 2028
Patients should maintain realistic expectations and understand that GLP-1 medications work best when combined with dietary modifications and increased physical activity
Glucagon-Like Peptide-1 Protects Beta-Cells Against Apoptosis by Increasing the Activity of an IGF-2/IGF-1 Receptor Autocrine Loop
US$ 21.08
US$ 20.95
US$ 25.70
US$ 29.57
US$ 22.18
US$ 20.82
